What Researchers Did
Researchers reviewed various pharmacological treatment techniques for cognitive disorders in geriatric subjects, focusing on neurochemical changes associated with aging and senile dementia.
What They Found
The study found that neurochemical changes like lower choline acetyltransferase and higher monoamine oxidase are more pronounced in senile dementia, Alzheimer's type. While most treatments have been unsuccessful, vasodilators like cyclandelate and hydergine showed potential value in some patients, and postsynaptic treatments such as physostigmine offered future hope.
What This Means for Canadian Patients
Canadian patients with cognitive disorders should be aware that this 1984 review highlights the historical challenges in finding effective pharmacological treatments. While specific treatments have advanced significantly since then, the review underscores the ongoing complexity of managing age-related cognitive decline and dementia.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation of this review is its publication date of 1984, meaning many discussed treatments and understandings have since been superseded by newer research.